New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Dr Reddy's Laboratories to revise the Phase II… Read More

New Delhi: The drug major Akum Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture… Read More

New Delhi: The drug major Akum Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the… Read More

The University of British Columbia, Simon Fraser University, and St. Michael’s Hospital at the University of Toronto have conducted a study investigating the genetic basis of severe CO… Read More

The COVID-19 pandemic has had a profound impact on global health, affecting millions of people worldwide. While progress has been made in treating and preventing acute COVID-19, there is gro… Read More

This episode features an interview with Dr. William Williams, CEO of BriaCell Therapeutics, a biotech company based in Philadelphia that is dedicated to developing novel immunotherapies to f… Read More

A disorder that causes hair loss and has traditionally been difficult to cure is called alopecia areata. Challenging to cure then because now individuals diagnosed with this condition could… Read More

Janus kinases (JAKs) belong to the non-receptor tyrosine kinase family, and their JAK-STAT signaling pathway with signal transducers and activators of transcription (STAT) can affect cell pr… Read More

Pfizer’s alopecia JAK inhibitor Litfulo (ritlecitinib) has become its fourth US Food and Drug Administration (FDA) approved product in the past several weeks. Litfulo is entering the a… Read More

Dabrafenib (GSK2118436) is a mutant BRAFV600-specific inhibitor, with an IC50 of 0.7 nM in cell-free assays. It shows 7-fold and 9-fold lower potency against B-Raf(wt) and c-Raf, respectivel… Read More

Overview Sinus infections and COVID-19 are respiratory conditions that can cause similar symptoms, leading to confusion and concern. But it is imperative to understand the critical differ… Read More

Arthritis is a term used to describe a group of diseases that primarily affect the joints in the body. It refers to inflammation and swelling of one or more joints, leading to pain… Read More

                                    Androgenetic Alopecia Treatment MarketOverview: There is a… Read More

Biotech AI is an emerging field that combines the principles of biotechnology with the capabilities of artificial intelligence (AI). Biotech AI uses machine learning algorithms and other tec… Read More

Summary: Brain cells exposed to blood taken from COVID-19 patients with delirium showed a decrease in neurogenesis and an increase in cell death. The findings also indicate a key role for c… Read More

We’re heading into our third winter with COVID-19 and, at this level, “there are only a few Individuals who haven’t been uncovered,” says infectious illness knowledge… Read More

Best Stocks to Invest in 2023 Investing in Stocks is not rocket science. People, on the other hand, are hesitant to invest in Stock Markets. Historical data and analysis have… Read More

Geoff Shackelford Ashwagandha, magnesium, hyaluronic acid, suma root extract, MSM, and L isoleucine are all natural and effective ingredients in this legal steroid alternative. According to… Read More

The global Tyrosine Kinase JAK Inhibitors Market is highly fragmented due to the presence of various large numbers of players which forms a competitive environment. The report enta… Read More

يعتبر تساقط الشعر مشكلة شائعة،
… Read More

DelveInsight’s, “Eczema Pipeline Insight, 2022” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers… Read More

Autoimmune Disease TreatmentThe immune system attacks its own body tissue as a result of an autoimmune disease. More than 80 different autoimmune disorders exist, although lupus, multiple sc… Read More

New guidance from the World Health Organization (WHO) strongly advises against using the antibody therapies sotrovimab and casirivimab-imdevimab to treat patients with COVID-19.This guidance… Read More

In 2001, the FDA approved Imatinib, the first drug to be developed by targeting a specific protein kinase and the first molecularly targeted drug to fight cancer. It was considered a milesto… Read More

Seguro te estás preguntando ¿Cuál es el primer fármaco contra la alopecia areata severa? pues se trata del nuevo fármaco Baricitinib, creado para controlar… Read More

Eli Lilly’s Olumiant (baricitinib) has won US Food and Drug Administration (FDA) approval as the first systemic treatment for severe alopecia areata (AA), an autoimmune disorder that l… Read More

Gilead’s Veklury (remdesivir) gets FDA approval to treat young children with COVID-19 and becomes the first and only approved COVID-19 treatment for children under 12. The world is in… Read More